Apr 22 |
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
|
Apr 4 |
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
|
Mar 27 |
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 2 |
RxSight, Inc. (NASDAQ:RXST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$57.75
|
Mar 1 |
RxSight Full Year 2023 Earnings: EPS Beats Expectations
|
Mar 1 |
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
|
Feb 29 |
RxSight, Inc. (NASDAQ:RXST) Q4 2023 Earnings Call Transcript
|
Feb 29 |
Q4 2023 Rxsight Inc Earnings Call
|
Feb 29 |
RxSight, Inc. (RXST) Q4 2023 Earnings Call Transcript
|
Feb 28 |
RxSight Non-GAAP EPS of -$0.13 beats by $0.14, revenue of $28.6M beats by $0.74M
|